Levothyroxine (L-thyroxine) is one of the most prescribed medicines in the world and effectively the only treatment for hypothyroidism. People take it for years, often for life, and that is exactly why so many questions collect around it: does free T3 need testing, why can’t TSH be checked after two weeks, can the tablet be washed down with coffee, and what happens if the dose turns out to be a little too high.
The good news: monitoring here is simple and rests almost entirely on a single marker. TSH is the main measure of both the effectiveness and the safety of treatment, and the other tests join in as the situation requires. The bad news: the mistakes usually happen in exactly the two places that look purely technical — how the sample is taken and how much time passes between tests — and that is how doses end up being changed blind.
This continues our series on lab monitoring while on medication — the same way we covered what to monitor while taking statins. What follows is about laboratory monitoring and its rhythm, not about choosing a dose: doses and regimens are a matter for your doctor. What the thyroid numbers themselves mean is covered in detail in our lab test reference and in the piece on what thyroid tests mean.
Why TSH is the main reference point on levothyroxine
The logic runs like this. The pituitary gland senses the level of thyroid hormones in the blood and adjusts its production of TSH, thyroid-stimulating hormone: too little hormone and TSH rises, too much and it falls. This feedback loop is more sensitive than any direct measurement, which is why in ordinary (primary) hypothyroidism it is TSH that shows whether the dose has hit its target.
The goal of treatment in primary hypothyroidism is to bring TSH back into the laboratory’s reference interval (usually somewhere around 0.4–4.0 mIU/L). As the American Thyroid Association guidelines for the treatment of hypothyroidism note, levothyroxine monotherapy remains the standard, and a normalized TSH remains the reference point. Particular groups of patients (older adults, pregnant women, people after surgery for thyroid cancer) have their own target ranges, which their doctor sets.
The second important point: the goal is a normal value, not a low one. The feeling that “I have more energy on a higher dose” is a poor guide. Below we look at exactly what the body pays for an overdose.
The 6–8 week rule: when to check TSH after starting and after a dose change
This is the main practical mistake — testing too early. Levothyroxine has a long half-life (about a week), and after treatment starts or the dose changes, the hormone level in the blood settles into its new equilibrium gradually. Hence the interval: both the StatPearls review of levothyroxine and the product labeling say to check TSH 6–8 weeks after starting therapy or changing the dose; the American Thyroid Association guidelines allow earlier monitoring, at 4–6 weeks, by which point equilibrium has been reached. If your doctor orders the test at five weeks, that is not a mistake.
What this means in practice:
- A test at 2–3 weeks shows an intermediate picture. Change the dose on the strength of it and it is easy to overshoot in the opposite direction.
- Doses are not changed more often than once every 4–8 weeks — otherwise it turns into chasing a number that has not settled yet.
- Once TSH has reached its target and is stable, the interval gets longer: monitoring is usually once every 6–12 months.
- An unscheduled test is needed when symptoms appear, in pregnancy, when the product or the manufacturer changes, after a sharp change in weight, and when adding medicines that affect the absorption or the metabolism of the hormone.
Wizey’s chief medical officer, Dr. Aigerim Bissenova, notes that one of the most common reasons for a puzzling TSH after a dose change is not the dose itself but missed tablets: the medicine is taken daily, and one or two missed doses a week shift the result noticeably. If doses do get missed, saying so honestly is more useful than changing the dose.
How to take the test so the number does not mislead you
Technique matters more here than it seems, because TSH is a marker with a daily rhythm of its own.
Time of day. TSH is higher at night and in the early morning and lower in the second half of the day; in one and the same person the difference between a morning and an afternoon value can be noticeable. Hence the rule: always test at roughly the same time, preferably in the morning — then the trend reflects the treatment rather than the clock on the wall.
Before or after the tablet. A single dose taken that day does not meaningfully affect TSH, but free T4 rises temporarily after it — by roughly 15% four hours later — and the result can be mistaken for an overdose. The practical solution: give blood in the morning before taking the tablet, and if the sample was taken afterwards, tell your doctor.
Biotin. Biotin supplements (vitamin B7, often in hair-and-nails formulas, sometimes at high doses) distort the results of many hormone tests, including TSH and T4 — the picture can look like thyrotoxicosis while thyroid function is normal. Biotin is usually stopped at least 2 days before the test, and the laboratory should always be told.
One laboratory. Reference intervals and assay methods differ between laboratories, so a trend is easier to follow within one of them — otherwise part of the “change” turns out to be a difference in methodology. Why the numbers differ we unpacked in the piece on why reference ranges vary and which to trust.
When TSH alone is not enough: free T4, T3, and antibodies
Free T4 is added to TSH in several situations: at the start of treatment, when the tests and how you feel do not match, when missed doses or impaired absorption are suspected, in pregnancy, and in severe hypothyroidism. There is also a special case — central (secondary) hypothyroidism, where the problem is not in the thyroid but in the pituitary. There TSH does not reflect the adequacy of treatment at all, and the reference point is free T4 in the upper half of the reference interval.
Free T3 is usually not needed for routine monitoring. On levothyroxine the body converts T4 into active T3 itself, and the level of free T3 adds little to a decision about the dose. That is also the answer to the popular question about combined T4 + T3 therapy: the ATA guidelines do not recommend it as a routine approach, and desiccated animal thyroid preparations are not recommended at all: they produce excessive T3 peaks and there is no long-term safety data.
TPO antibodies (anti-TPO) are needed once — to establish the nature of the hypothyroidism (autoimmune thyroiditis or another cause). There is no point in repeating them “to follow the trend”: a falling or rising titer does not change management and does not reflect how well treatment is working. The same goes for regular thyroid ultrasound in compensated hypothyroidism without nodules — it is not required on a schedule.
Too much and too little: what is actually at risk
Too much. An excessive dose produces a low or suppressed TSH — a state that is essentially a drug-induced (iatrogenic) subclinical thyrotoxicosis. It is rarely felt as “poisoning,” but it has a measurable price. First, the heart: in the data the ATA guidelines draw on, people over 65 with a TSH below 0.1 mIU/L had roughly three times the risk of atrial fibrillation over 10 years of follow-up compared with people whose TSH was normal. That is exactly why the guidelines specifically recommend avoiding TSH values below 0.1 mIU/L in older adults and in postmenopausal women. Second, the bones: according to the BMJ study on levothyroxine dose and fracture risk in older adults, fracture risk in patients over 70 depends on the dose of the medicine. Typical symptoms of excess are palpitations, skipped beats, tremor, sweating (including night sweats), insomnia, anxiety, and weight loss.
Too little. A high TSH during treatment means the hypothyroidism is not compensated: fatigue, feeling cold, puffiness, constipation, dry skin, hair loss, and brain fog persist. There is a laboratory consequence too — untreated hypothyroidism raises LDL, and as TSH normalizes the lipid profile often improves on its own. That is why it makes more sense to assess lipids after compensation is reached rather than in the middle of dose titration.
One thing worth stating separately, because almost everyone asks about it: levothyroxine is not a weight-loss drug. Taking an excessive dose to lose weight gives a minimal and short-lived effect, and fully fledged risks to the heart and bones.
What interferes with absorption: food, coffee, calcium, iron, PPIs
Levothyroxine is fussy about the conditions in which it is taken — and this is the most common reason for an “inexplicably high” TSH in a disciplined patient.
The basic rule for taking it: on an empty stomach, 30–60 minutes before breakfast, with water. The alternative for those for whom mornings are inconvenient is to take it at bedtime, at least 3–4 hours after the last meal. What matters is not to alternate between schedules but to pick one.
Coffee. Coffee drunk together with the tablet cuts absorption by roughly a quarter to a third. This is not a ban on coffee but a request to wait: in the study where the interference disappeared, the interval was an hour.
Medicines and supplements to separate by 4 hours. According to the StatPearls review and the product labeling, absorption is meaningfully reduced by calcium supplements, iron supplements, aluminum- and magnesium-containing antacids, sevelamer, cholestyramine, and colesevelam; these are separated from levothyroxine by at least 4 hours. For calcium this applies to all the common salts: in the Thyroid study on levothyroxine taken together with calcium formulations, carbonate, citrate, and acetate reduced absorption to about the same degree. A practical nuance: if you are treating iron deficiency and taking levothyroxine at the same time, space them apart — otherwise both prescriptions suffer. How to monitor the deficiency itself is covered on the ferritin page.
Proton pump inhibitors (omeprazole and similar drugs) reduce stomach acidity, and levothyroxine is absorbed better in an acidic environment. Here spacing the doses out does not solve the problem: with long-term PPI use you need TSH monitoring and, possibly, a dose adjustment from your doctor. There is also discussion of liquid formulations of levothyroxine, which are less sensitive to interactions of this kind, though their availability varies from country to country and they are far from being stocked everywhere.
What raises the dose requirement. A separate group affects not absorption but hormone metabolism: estrogens (combined contraceptives, menopausal hormone therapy) increase the amount of carrier protein, while anticonvulsants and rifampin speed up the breakdown of the hormone. When such treatment is started, it makes sense to recheck TSH.
Food and the state of the gut. Soy products, large amounts of fiber, and diseases — celiac disease, atrophic gastritis, Helicobacter pylori infection, the state after bariatric surgery — all impair absorption. If TSH stubbornly refuses to normalize despite clearly correct dosing, these causes are looked for separately.
Special situations: pregnancy, older age, thyroid surgery
Pregnancy. Here the monitoring regimen changes radically: the requirement for hormone rises already in the first trimester. According to the American Thyroid Association 2026 guidelines on thyroid disease in pregnancy, women on levothyroxine have TSH checked when pregnancy is confirmed, then roughly every 4 weeks through the first half of pregnancy, at least once in the third trimester, and 4–6 weeks after a dose change. For those planning a pregnancy the usual target is a TSH in the range of 0.5–2.5 mIU/L, and the dose increases as the pregnancy progresses: on average by about a quarter by week 12 and by about half by week 20. A practice the guidelines explicitly call reasonable is to agree with your doctor in advance to increase the dose by about a quarter as soon as the test is positive (for example, by adding two extra tablets a week). The key part here is “in advance”: this is a plan drawn up by a doctor before pregnancy, not a decision made on your own on the strength of two lines on a test.
Older age. With the years the upper limit of the normal TSH range naturally shifts upward, while the heart’s sensitivity to an excess of hormone grows. That is why in older adults the target TSH is usually higher, the dose is built up slowly and in small steps, and a suppressed TSH is considered undesirable. What else changes in the panel of tests with age is covered in the piece on a checkup after 50.
After thyroid surgery. If levothyroxine was prescribed after removal of the gland for cancer, the target TSH is determined by the risk of recurrence and may be deliberately lowered (suppressive therapy). Monitoring then adds thyroglobulin with its antibodies as a follow-up tumor marker, and after a thyroidectomy calcium and parathyroid hormone are monitored as well. That regimen is run by an endocrinologist and has nothing to do with ordinary hypothyroidism.
Concomitant deficiencies. In autoimmune thyroiditis other autoimmune conditions occur more often — celiac disease and atrophic gastritis, and with them deficiencies of iron and vitamin B12. If fatigue persists while TSH is normal, it is sensible to check those rather than raise the hormone dose: why B12 deficiency is missed so often we unpacked in a separate piece.
The monitoring calendar in brief
This is a reference point for the conversation with your doctor — the exact frequency is theirs to set.
| What | When | Why |
|---|---|---|
| TSH | 4–8 weeks after starting and after every dose change (product labeling — 6–8, ATA — 4–6) | Whether the dose has hit its target |
| TSH | Once every 6–12 months on a stable dose | Routine monitoring |
| Free T4 | At the start of treatment; when tests and symptoms do not match; in pregnancy; always in central hypothyroidism | Clarifying the picture |
| Free T3 | Not needed routinely | Only if your doctor decides otherwise |
| Anti-TPO | Once, at diagnosis | The nature of the hypothyroidism, not monitoring |
| Lipid panel | After compensation is reached | Hypothyroidism raises LDL |
| Ferritin, vitamin B12 | When fatigue persists on a normal TSH | Concomitant deficiencies |
| TSH in pregnancy | At confirmation, every 4 weeks through the first half, at least once in the third trimester, and 4–6 weeks after a dose change | Rising hormone requirement |
Red flags: when to see a doctor without waiting for the scheduled test
- Palpitations, skipped beats, tremor, insomnia, sweating, weight loss — possible signs of an overdose; an unscheduled TSH is needed.
- Chest pain or marked shortness of breath after starting or increasing the dose — a reason to seek medical help without delay.
- Pregnancy or planning one — tell your doctor straight away, the monitoring regimen changes.
- Starting calcium, iron, antacids, PPIs, or estrogens (including contraceptives and menopausal hormone therapy) — the dose requirement may change.
- A change of manufacturer — TSH is worth rechecking in 6–8 weeks.
Frequently asked questions
How long after starting or changing the dose should I test TSH? The reference point is 6–8 weeks according to the product labeling; the American Thyroid Association guidelines allow 4–6 weeks. Earlier than four weeks the test makes no sense: levothyroxine clears slowly, the level has not yet reached its new equilibrium, and the result can lead to a wrong dose adjustment. Once the target is reached, TSH is checked roughly once every 6–12 months.
Do I need to test TSH before taking the morning tablet? Taking the tablet that day does not meaningfully affect TSH itself, but free T4 rises temporarily afterwards, so it is more convenient to give blood in the morning before the dose. The main thing is to test under the same conditions every time: at roughly the same time of day and in the same relation to the tablet, otherwise ordinary fluctuation is easily mistaken for a trend.
Is TSH alone enough, or is free T4 needed too? In ordinary (primary) hypothyroidism, TSH is enough for routine monitoring. Free T4 is added at the start of treatment, when the tests and how you feel do not match, when missed doses or impaired absorption are suspected, in pregnancy, and in central hypothyroidism — there TSH is uninformative and T4 is what treatment is guided by.
What are the risks of too high a levothyroxine dose? An excess of hormone creates a hidden thyrotoxicosis: a low TSH is linked to a higher risk of atrial fibrillation and, in older adults, to loss of bone mass and fractures, with the risk depending on the dose. That is why the goal of treatment is a normal TSH rather than the pursuit of extra energy: you must not raise the dose on your own for the sake of alertness or weight loss.
What interferes with levothyroxine absorption? Food in general, coffee (it cuts absorption by roughly a quarter to a third), calcium, iron and magnesium supplements, aluminum-containing antacids, proton pump inhibitors, soy products, and a high fiber content. The tablet is taken on an empty stomach 30–60 minutes before breakfast, coffee is pushed back by about an hour, and calcium, iron, and similar products are separated from it by at least 4 hours. With proton pump inhibitors, spacing them out does not work — there you need TSH monitoring and a decision from your doctor.
How should TSH be monitored during pregnancy on levothyroxine? More often than usual: a test as soon as pregnancy is confirmed, then roughly every 4 weeks through the first half of pregnancy, at least once in the third trimester, and 4–6 weeks after any dose change. The requirement for the medicine usually rises, so the dose is reviewed by the doctor — there is no need to change it yourself.
Conclusion
Monitoring on levothyroxine rests on three rules: TSH 6–8 weeks after every dose change, then once every 6–12 months; testing under the same conditions and at the same laboratory; and strict technique in taking the tablet, with intervals from coffee, calcium, and iron. Everything else — free T4, antibodies, thyroglobulin — is added on specific indications, not for the sake of a complete picture.
If lab forms are piling up and the connection between TSH, the dose, and how you feel keeps slipping away, that is what we build Wizey for: it helps line your markers up over time and prepare questions for your endocrinologist. It is not a substitute for a consultation and not a tool for choosing a dose, but a way to arrive at the appointment with a clear history rather than a stack of separate results.
